Animal tuberculosis (TB) attributable to Mycobacterium tuberculosis complicated (MTC) micro organism stays as some of the vital infectious ailments of livestock, regardless of a long time of eradication applications and analysis efforts, in an period the place the livestock sector is amongst a very powerful and quickly increasing industrial agricultural segments worldwide. This work offers a worldwide overview of the spatial and temporal tendencies of reported scientific data of TB in livestock, aiming to achieve insights into analysis subtopics throughout the animal TB epidemiology area and to focus on territorial inequalities concerning information reporting and analysis outputs over time. To ship such data, peer-reviewed studies of TB research in livestock had been retrieved from the Internet of Science and Google Scholar, systematized, and dissected.

The validated dataset contained 443 prevalence observations, protecting the 1981-2020 interval (39 years). We spotlight a transparent transfer in the direction of transdisciplinary areas and the One Well being method, with a worldwide temporal improve of publications combining livestock with wildlife and/or human parts, which replicate the significance of non-prototypical hosts as key to understanding animal TB. It turns into evident that cattle is the principle host throughout works from all continents, nonetheless many areas stay poorly surveyed.

Read Latest Articles: https://www.tbdb.org/how-accurate-are-covid-19-pcr-tests/

TB analysis in livestock in low-/middle-income international locations is markedly rising, reflecting modifications in animal husbandry, but in addition mirroring the globalization period, with a marked improve in worldwide collaboration and capacitation applications for scientific and technological improvement. This overview offers an outline of probably the most prolific continents, international locations, and analysis fields in animal TB epidemiology, clearly outlining data gaps and key precedence subjects. The estimated development pattern of livestock manufacturing till 2050, notably in Asia and Africa, in response to human inhabitants development and animal-protein demand, would require additional funding in early surveillance and adaptive analysis to accommodate the upper range of livestock species and MTC members and elevating the likelihood to finetune funding schemes.

Can a tuberculosis analysis program promoted by a scientific society contribute to the management of the illness?

Though Spain is a developed nation, Tuberculosis (TB) was for years a illness with excessive incidence charges in comparison with different European international locations, a state of affairs that worsened with the HIV/AIDS epidemic and with the rise of immigration. The Spanish Respiratory Society (SEPAR) created in 2004 the Built-in Analysis Applications (PII) on respiratory ailments, together with TB (PII-TB) which has carried out research associated to the 5 traces of analysis that it maintains: medical / epidemiological, microbiological, technological/medical administration, evaluative, and worldwide cooperation.
Following the suggestions on the need to guage well being applications made by worldwide organizations, the analysis of PII-TB was not too long ago carried out, revealing the state of affairs of the principle variables of the illness and their evolution over the time that this system has been working. PII-TB has generated considerable information on the state of affairs of this illness in our nation in years when this data has been restricted. The truth that the outcomes of the research have been extensively disseminated makes it simpler for all professionals concerned within the prevention, prognosis and remedy of TB to implement and/or to enhance actions that, lastly, will contribute to the management of this illness.
A pesar de que España es un país desarrollado, la tuberculosis (TB) fue durante años una enfermedad con importantes tasas de incidencia con respecto a otros países europeos, situación que empeoró con la epidemia del VIH/SIDA y el aumento de la inmigración. Como consecuencia de la situación, SEPAR crea en el año 2004 los Programas Integrados de Investigación (PII), entre los que se incluye la TB (PII-TB). Dicho programa ha llevado a cabo estudios relacionados con alguna de las cinco líneas de investigación que éste mantiene: clínica/epidemiológica, microbiológica, tecnológica/gestión clínica, evaluativa y de cooperación internacional.
Siguiendo las recomendaciones sobre la necesidad de evaluar los programas de salud que hacen los organismos internacionales, se realizó recientemente la evaluación del PII-TB, lo que ha permitido conocer la situación de las principales variables de la enfermedad a lo largo de los años de funcionamiento del programa y la evolución de las mismas. El PII-TB ha generado abundantes datos sobre la situación de esta enfermedad en nuestro país durante unos años en que esta información ha sido limitada. El hecho de que los resultados de los estudios hayan sido extensamente difundidos, facilita que todos los profesionales implicados en la prevención, diagnóstico y tratamiento de la TB puedan implementar y/o mejorar last actividades que, en definitiva, contribuirán a mejorar el management de esta enfermedad.
Global trends of epidemiological research in livestock tuberculosis for the last four decades

Superior imaging instruments for childhood tuberculosis: potential purposes and analysis wants

Tuberculosis is the main explanation for loss of life globally that is because of a single pathogen, and as much as a fifth of sufferers with tuberculosis in high-incidence international locations are youngsters youthful than 16 years. Sadly, the prognosis of childhood tuberculosis is difficult as a result of the illness is commonly paucibacillary and it’s troublesome to acquire appropriate specimens, inflicting poor sensitivity of at the moment accessible pathogen-based checks.
Chest radiography is essential for diagnostic evaluations as a result of it detects abnormalities per childhood tuberculosis, however a number of limitations exist within the interpretation of such outcomes. Subsequently, different imaging strategies have to be systematically evaluated in youngsters with tuberculosis, though present information counsel that when accessible, cross-sectional imaging, comparable to CT, needs to be thought-about within the diagnostic analysis for tuberculosis in a symptomatic youngster.
Moreover, a lot of the understanding of childhood tuberculosis stems from medical specimens that may not precisely signify the lesional biology at an infection websites. By offering non-invasive measures of lesional biology, superior imaging instruments might improve the understanding of fundamental biology and enhance on the poor sensitivity of present pathogen detection methods.

Mycobacterium tuberculosis 16kD (M. tuberculosis)

MBS6011625-5x1mg 5x1mg
EUR 5675

Mycobacterium tuberculosis (M. tuberculosis) Antibody

abx415707-1ml 1 ml
EUR 727.2

Mycobacterium tuberculosis (M. tuberculosis) Antibody

abx415707-200l 200 µl
EUR 537.5

Mycobacterium tuberculosis, HSP, Recombinant

MBS636978-01mg 0.1mg
EUR 735

Mycobacterium tuberculosis, HSP, Recombinant

MBS636978-5x01mg 5x0.1mg
EUR 3165

M. Tuberculosis HSP70 Protein

abx060544-100ug 100 ug
EUR 1378.8

Mycobacterium tuberculosis 16kD (M. tuberculosis) (PE)

MBS6129466-01mL 0.1(mL
EUR 1240

Mycobacterium tuberculosis 16kD (M. tuberculosis) (PE)

MBS6129466-5x01mL 5x0.1mL
EUR 5430

Mycobacterium tuberculosis 16kD (M. tuberculosis) (PE)

MBS6129467-01mL 0.1(mL
EUR 1095

Mycobacterium tuberculosis 16kD (M. tuberculosis) (PE)

MBS6129467-5x01mL 5x0.1mL
EUR 4775

Mycobacterium tuberculosis 16kD (M. tuberculosis) (AP)

MBS6126370-01mL 0.1(mL
EUR 1240

Mycobacterium tuberculosis 16kD (M. tuberculosis) (AP)

MBS6126370-5x01mL 5x0.1mL
EUR 5430

Mycobacterium tuberculosis 16kD (M. tuberculosis) (AP)

MBS6126371-01mL 0.1(mL
EUR 1095

Mycobacterium tuberculosis 16kD (M. tuberculosis) (AP)

MBS6126371-5x01mL 5x0.1mL
EUR 4775

Mycobacterium tuberculosis 16kD (M. tuberculosis) (HRP)

MBS6128846-01mL 0.1(mL
EUR 1240

Mycobacterium tuberculosis 16kD (M. tuberculosis) (HRP)

MBS6128846-5x01mL 5x0.1mL
EUR 5430

Mycobacterium tuberculosis 16kD (M. tuberculosis) (HRP)

MBS6128847-01mL 0.1(mL
EUR 1095

Mycobacterium tuberculosis 16kD (M. tuberculosis) (HRP)

MBS6128847-5x01mL 5x0.1mL
EUR 4775

Mycobacterium tuberculosis 16kD (M. tuberculosis) (APC)

MBS6126990-01mL 0.1(mL
EUR 1240

Mycobacterium tuberculosis 16kD (M. tuberculosis) (APC)

MBS6126990-5x01mL 5x0.1mL
EUR 5430

Mycobacterium tuberculosis 16kD (M. tuberculosis) (APC)

MBS6126991-01mL 0.1(mL
EUR 1095

Mycobacterium tuberculosis 16kD (M. tuberculosis) (APC)

MBS6126991-5x01mL 5x0.1mL
EUR 4775

Mycobacterium tuberculosis 16kD (M. tuberculosis) (FITC)

MBS6128225-01mL 0.1(mL
EUR 1240

Mycobacterium tuberculosis 16kD (M. tuberculosis) (FITC)

MBS6128225-5x01mL 5x0.1mL
EUR 5430

Mycobacterium tuberculosis 16kD (M. tuberculosis) (FITC)

MBS6128226-01mL 0.1(mL
EUR 1095

Mycobacterium tuberculosis 16kD (M. tuberculosis) (FITC)

MBS6128226-5x01mL 5x0.1mL
EUR 4775

Recombinant M. Tuberculosis HSP65

DAGA-194 0.1 mg Ask for price

Mycobacterium tuberculosis 16kD (M. tuberculosis) (Biotin)

MBS6127611-01mL 0.1(mL
EUR 1240

Mycobacterium tuberculosis 16kD (M. tuberculosis) (Biotin)

MBS6127611-5x01mL 5x0.1mL
EUR 5430

Mycobacterium tuberculosis 16kD (M. tuberculosis) (Biotin)

MBS6127612-01mL 0.1(mL
EUR 1095

Mycobacterium tuberculosis 16kD (M. tuberculosis) (Biotin)

MBS6127612-5x01mL 5x0.1mL
EUR 4775

M. Tuberculosis LAM

DAGA-168 1 mg
EUR 1434

M. Tuberculosis MPT53

DAGA-171 100 µg
EUR 868.8

Recombinant Mycobacterium Tuberculosis HSP Protein

VAng-Yyj0063-10g 10 µg
EUR 2250
Description: Mycobacterium Tuberculosis, HSP, recombinant protein.

M. Tuberculosis 38 kDa

DAG-T2447 1 mg Ask for price

M. Tuberculosis 16 kDa

DAG-T2449 1 mg Ask for price

M. Tuberculosis 15.3 kDa

DAGA-169 1 mg
EUR 1170

MAb to M. tuberculosis

MBS310270-1mg 1mg
EUR 955

MAb to M. tuberculosis

MBS310270-5x1mg 5x1mg
EUR 4115

MAb to M. tuberculosis

MBS310271-1mg 1mg
EUR 1035

MAb to M. tuberculosis

MBS310271-5x1mg 5x1mg
EUR 4485

MAb to M. tuberculosis

MBS310272-1mg 1mg
EUR 1035

MAb to M. tuberculosis

MBS310272-5x1mg 5x1mg
EUR 4485

MAb to M. tuberculosis

MBS310273-1mg 1mg
EUR 1035

MAb to M. tuberculosis

MBS310273-5x1mg 5x1mg
EUR 4485

Mouse antibody for M. tuberculosis Hsp65

5177 100 ug
EUR 386.26
Description: This is purified Mouse monoclonal antibody against M tuberculosis Hsp65 for WB, ELISA.

Mouse antibody for M. tuberculosis Hsp65

5178 100 ug
EUR 386.26
Description: This is purified Mouse monoclonal antibody against M tuberculosis Hsp65 for WB, ELISA.

Mycobacterium tuberculosis HSP 70 Recombinant Protein

53-349 0.01 mg
EUR 789.9
Description: Mycobacterium tuberculosis HSP 70 Recombinant Protein

Rabbit A' M. tuberculosis

MBS315160-1mL 1mL
EUR 855

Rabbit A' M. tuberculosis

MBS315160-5x1mL 5x1mL
EUR 3685

Rabbit A' M. tuberculosis

MBS315161-1mL 1mL
EUR 915

Rabbit A' M. tuberculosis

MBS315161-5x1mL 5x1mL
EUR 3945

Rabbit A' M. tuberculosis

MBS315162-1mL 1mL
EUR 915

Rabbit A' M. tuberculosis

MBS315162-5x1mL 5x1mL
EUR 3945

Rabbit A' M. tuberculosis

MBS315163-1mL 1mL
EUR 800

Rabbit A' M. tuberculosis

MBS315163-5x1mL 5x1mL
EUR 3420

M. Tuberculosis TB22.2 Antigen

DAGA-186 100 µg
EUR 868.8

M. tuberculosis Moex protein

MBS596054-1mg 1mg
EUR 425

M. tuberculosis Moex protein

MBS596054-2mg 2mg
EUR 700

M. tuberculosis Moex protein

MBS596054-5mg 5mg
EUR 1505

M. tuberculosis CFP10, Recomb.

MBS319838-01mg 0.1mg
EUR 755

M. tuberculosis CFP10, Recomb.

MBS319838-5x01mg 5x0.1mg
EUR 3165

M. tuberculosis CFP10, Protein

abx061400-100ug 100 ug
EUR 961.2

M. tuberculosis ESAT6, Protein

abx061402-100ug 100 ug
EUR 910.8

M. Tuberculosis Mpt70 Antigen

DAGA-182 100 µg
EUR 868.8

M. Tuberculosis MPT83 Antigen

DAGA-183 100 µg
EUR 868.8

M. Tuberculosis Mpt64 Antigen

DAGA-184 100 µg
EUR 868.8

M. tuberculosis CFP10 Protein

abx061400-100g 100 µg Ask for price

M. tuberculosis CFP10 Protein

abx061400-10g 10 µg
EUR 1100

M. tuberculosis CFP10 Protein

abx061400-50g 50 µg Ask for price

Monoclonal Anti-M. tuberculosis Heat Shock Protein 65 (hsp65/groEL-2/Cpn60-2) IgG

HSP651-M 100 ul
EUR 578.4

M. Tuberculosis Rv2672 Antigen

DAGA-174 100 µg
EUR 868.8

M. Tuberculosis Rv2253 Antigen

DAGA-177 100 µg
EUR 868.8

M. Tuberculosis MT3413 Antigen

DAGA-178 100 µg
EUR 868.8

M. Tuberculosis Rv0477 Antigen

DAGA-179 100 µg
EUR 868.8

M. Tuberculosis Rv0192A Antigen

DAGA-173 100 µg
EUR 868.8

M. Tuberculosis Rv0398c Antigen

DAGA-176 100 µg
EUR 868.8

Mycobacterium tuberculosis 38 kDa Antigen (M. tuberculosis 38 kDa) Antibody

abx411025-02mg 0.2 mg
EUR 678

Mycobacterium tuberculosis 16 kDa Antigen (M. tuberculosis 16 kDa) Antibody

abx415759-01mg 0.1 mg
EUR 760.8

Mycobacterium tuberculosis 16 kDa Antigen (M. tuberculosis 16 kDa) Antibody

abx415759-200l 200 µl
EUR 600

Mycobacterium tuberculosis 38 kDa Antigen (M. tuberculosis 38 kDa) Antibody

abx411025-100g 100 µg
EUR 487.5

Mab to M. tuberculosis MPT64

MBS313702-1mg 1mg
EUR 515

Mab to M. tuberculosis MPT64

MBS313702-5x1mg 5x1mg
EUR 2135

Mab to M. tuberculosis MPT64

MBS313703-1mg 1mg
EUR 515

Mab to M. tuberculosis MPT64

MBS313703-5x1mg 5x1mg
EUR 2135

Mab to M. tuberculosis MPT64

MBS313704-1mg 1mg
EUR 515

Mab to M. tuberculosis MPT64

MBS313704-5x1mg 5x1mg
EUR 2135

Mab to M. tuberculosis MPT64

MBS313705-1mg 1mg
EUR 515

Mab to M. tuberculosis MPT64

MBS313705-5x1mg 5x1mg
EUR 2135

M. tuberculosis MPT64 Rec. Ag

MBS313721-1mg 1mg
EUR 515

M. tuberculosis MPT64 Rec. Ag

MBS313721-5x1mg 5x1mg
EUR 2155

M. tuberculosis MPT64 Rec. Ag

MBS313722-1mg 1mg
EUR 515

M. tuberculosis MPT64 Rec. Ag

MBS313722-5x1mg 5x1mg
EUR 2155

MAb to M. tuberculosis, 16kDa

MBS310461-1mg 1mg
EUR 605

MAb to M. tuberculosis, 16kDa

MBS310461-5x1mg 5x1mg
EUR 2640

MAb to M. tuberculosis, 38kDa

MBS310523-1mg 1mg
EUR 605

MAb to M. tuberculosis, 38kDa

MBS310523-5x1mg 5x1mg
EUR 2640

MAb to M. tuberculosis CFP10

MBS312553-1mg 1mg
EUR 805

MAb to M. tuberculosis CFP10

MBS312553-5x1mg 5x1mg
EUR 3455

MAb to M. tuberculosis CFP10

MBS312555-1mg 1mg
EUR 805

MAb to M. tuberculosis CFP10

MBS312555-5x1mg 5x1mg
EUR 3455

Recombinant M. tuberculosis 38kD

DAG-WT1091 1 mg
EUR 480
Description: Recombinant

M. tuberculosis, 38kDa, Recombinant

MBS319392-01mg 0.1mg
EUR 1150

M. tuberculosis, 38kDa, Recombinant

MBS319392-5x01mg 5x0.1mg
EUR 4995

Heat Shock Protein 65, Recombinant, Mycobacterium tuberculosis (HSP65)

MBS636130-0002mg 0.002mg
EUR 390

Heat Shock Protein 65, Recombinant, Mycobacterium tuberculosis (HSP65)

MBS636130-001mg 0.01mg
EUR 540

Heat Shock Protein 65, Recombinant, Mycobacterium tuberculosis (HSP65)

MBS636130-5x001mg 5x0.01mg
EUR 2275

M. Tuberculosis 38 kDa Protein

abx060636-100ug 100 ug
EUR 978

M. Tuberculosis 85-C Antigen

DAGA-175 100 µg
EUR 868.8

M. Tuberculosis 85-A Antigen

DAGA-181 100 µg
EUR 868.8

M. Tuberculosis 85-B Antigen

DAGA-185 100 µg
EUR 868.8

M. Tuberculosis 48 kDa protein

DAGA-191 1 mg Ask for price

M. Tuberculosis 38 kDa Protein

abx060636-100g 100 µg Ask for price

M. Tuberculosis 38 kDa Protein

abx060636-10g 10 µg
EUR 1437.5

M. Tuberculosis 38 kDa Protein

abx060636-50g 50 µg Ask for price

M. Tuberculosis 85A Antigen[his]

DAGA-189 10 µg
EUR 812.4

M. Tuberculosis 85A Antigen [His]

DAGA-192 50 µg
EUR 1228.8

M. Tuberculosis ESAT-6 Antigen

DAGA-187 100 µg
EUR 868.8

Native M. Tuberculosis LAM antigen

DAGC601 10 ug
EUR 978.6
Description: Native

Anti-Tb7.7 (M. tuberculosis) Purified

11-190-C100 0.1 mg
EUR 198

M. Tuberculosis Mpt63/MPB63 Antigen

DAGA-180 100 µg
EUR 868.8

Anti-Tb7.7 (M. tuberculosis) Purified

MBS1801449-01mg 0.1mg
EUR 305

Anti-Tb7.7 (M. tuberculosis) Purified

MBS1801449-5x01mg 5x0.1mg
EUR 1120

Anti-Acr1 (M. tuberculosis) Purified

11-185-C100 0.1 mg
EUR 198

Anti-Tb10.4 (M. tuberculosis) Purified

11-186-C100 0.1 mg
EUR 198

Anti-Tb10.3 (M. tuberculosis) Purified

11-187-C100 0.1 mg
EUR 198

Anti-Acr2 (M. tuberculosis) Purified

11-188-C100 0.1 mg
EUR 198

Anti-GlcB (M. tuberculosis) Purified

11-192-C100 0.1 mg
EUR 198

Recombinant M. Tuberculosis CFP-10

DAGA-170 1 mg
EUR 790.8

Anti-Acr1 (M. tuberculosis) Purified

MBS1801444-01mg 0.1mg
EUR 305

Anti-Acr1 (M. tuberculosis) Purified

MBS1801444-5x01mg 5x0.1mg
EUR 1120

Anti-Tb10.4 (M. tuberculosis) Purified

MBS1801445-01mg 0.1mg
EUR 305

Anti-Tb10.4 (M. tuberculosis) Purified

MBS1801445-5x01mg 5x0.1mg
EUR 1120

Anti-Tb10.3 (M. tuberculosis) Purified

MBS1801446-01mg 0.1mg
EUR 305

Anti-Tb10.3 (M. tuberculosis) Purified

MBS1801446-5x01mg 5x0.1mg
EUR 1120

Anti-Acr2 (M. tuberculosis) Purified

MBS1801447-01mg 0.1mg
EUR 305

Anti-Acr2 (M. tuberculosis) Purified

MBS1801447-5x01mg 5x0.1mg
EUR 1120

Anti-GlcB (M. tuberculosis) Purified

MBS1801450-01mg 0.1mg
EUR 305

Anti-GlcB (M. tuberculosis) Purified

MBS1801450-5x01mg 5x0.1mg
EUR 1120

Anti-Ag85b (M. tuberculosis) Purified

11-189-C100 0.1 mg
EUR 198

Anti-Ag85b (M. tuberculosis) Purified

MBS1801448-01mg 0.1mg
EUR 305

Anti-Ag85b (M. tuberculosis) Purified

MBS1801448-5x01mg 5x0.1mg
EUR 1120

M. Tuberculosis 63 kDa protein [His]

DAGA-190 1 mg Ask for price

Bacteria-Derived tuberculosis HSP 70 Recombinant Protein liquid

IBCTMYCBCTTBHSP70R10UG each
EUR 948
Description: Bacteria-Derived tuberculosis HSP 70 Recombinant Protein liquid

Bacteria-Derived tuberculosis HSP 70 Recombinant Protein liquid

MBS8430610-INQUIRE INQUIRE Ask for price

Zmp1 M. tuberculosis Recombinant Protein

90-361 50 ug
EUR 752.1
Description: M13 endopeptidases are single-pass, transmembrane zinc-metallopeptidases responsible in human for the regulation of the biological activity of many hormones and peptides and are involved in many important processes such as blood pressure regulation (Neprilysin or NEP1), cardiovascular development (Endothelin Converting Enzyme-1 or ECE-12), prevention of haemolytic reaction (KELL) and phosphate homeostasis (PHEX). Zmp1 is a soluble enzyme member of the M13 endopeptidases family that plays a key role in Mycobacterium tuberculosis pathogenicity with a still unknown mechanism. Recently, it was shown to suppress inflammasome activation by inhibiting caspase-1 activation, thus preventing processing of pro-IL-1beta into IL-1beta and the consequent phagosome maturation.

Recombinant M. Tuberculosis Moex antigen

DAGA-213 1 mg Ask for price

Myobacterium Tuberculosis Heat Shock Protein 65 Protein

20-abx263477
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 2 µg

Myobacterium Tuberculosis Heat Shock Protein 65 Protein

abx263477-10mg 10 mg
EUR 1362.5

Myobacterium Tuberculosis Heat Shock Protein 65 Protein

abx263477-1mg 1 mg
EUR 225

Myobacterium Tuberculosis Heat Shock Protein 65 Protein

abx263477-5mg 5 mg
EUR 325

OPMA04822-100UG - M. tuberculosis Protein

OPMA04822-100UG 0.1MG
EUR 849

M. Tuberculosis EsxB (LHP) (CFP10) Antigen

DAGA-188 100 µg
EUR 868.8

M. Tuberculosis ClpP Protease Assay Kit

TBP100K 100 assays
EUR 278.4
Description: This product includes 3100 ul of Assay Buffer and 310 ul of 10 x Substrate and 3500 ul of Stop solution. It is for 100 assays in 384-well plate format

Anti-CFP-10 (M. tuberculosis) Purified

11-490-C025 0.025 mg
EUR 99

Anti-CFP-10 (M. tuberculosis) Purified

11-490-C100 0.1 mg
EUR 198

Anti-ESAT-6 (M. tuberculosis) Purified

11-491-C025 0.025 mg
EUR 99

Anti-ESAT-6 (M. tuberculosis) Purified

11-491-C100 0.1 mg
EUR 198

Mouse antibody for M. tuberculosis 38kDa

5174 100 ug
EUR 386.26
Description: This is purified Mouse monoclonal antibody against M tuberculosis 38kDa for WB, ELISA.

Recombinant M. tuberculosis CFP10 (No tag)

DAG-WT1769 1 mg
EUR 1460
Description: Recombinant

Anti-CFP-10 (M. tuberculosis) Purified

MBS1801463-01mg 0.1mg
EUR 305

Anti-CFP-10 (M. tuberculosis) Purified

MBS1801463-5x01mg 5x0.1mg
EUR 1120

Anti-ESAT-6 (M. tuberculosis) Purified

MBS1801464-01mg 0.1mg
EUR 305

Anti-ESAT-6 (M. tuberculosis) Purified

MBS1801464-5x01mg 5x0.1mg
EUR 1120

Recombinant Myobacterium Tuberculosis Heat Shock Protein 65

7-07048 2µg Ask for price

Recombinant Myobacterium Tuberculosis Heat Shock Protein 65

7-07049 10µg Ask for price
Lastly, there are key data gaps concerning using imaging instruments for childhood tuberculosis that we outlined on this Private View, along with a proposed roadmap for future analysis.

LEAVE A REPLY

Please enter your comment!
Please enter your name here